细胞外囊泡表面标志物作为短暂性脑缺血发作的诊断工具
研究分析了40例疑似TIA患者和20例健康对照的训练队列,以及28例独立外部验证队列,用流式细胞术检测EV表面抗原谱并构建预测模型。结果显示EV浓度在很可能或可能- probable TIA患者中升高(P<0.05),且与精确诊断评分直接相关(R=0.712;P<0.001)。基于选定标志物的随机森林模型在训练队列和外部验证队列中区分很可能TIA的准确率分别为96%和78.9%。
要点
- EV浓度在很可能或可能- probable TIA患者中较对照升高(P<0.05)。
- EV浓度与精确诊断评分直接相关(R=0.712;P<0.001)。
- 随机森林模型区分很可能TIA的准确率训练队列96%、外部验证78.9%。
核心结论
- 疑似TIA患者中,症状归因为很可能脑缺血者的EV表面抗原谱与症状不太可能由脑缺血引起者不同。
- 基于EV表面抗原特征的算法可能有助于TIA的识别。
研究设计与样本
- 训练队列纳入40例疑似TIA症状者和20例健康对照,独立外部验证队列28例。
- 用纳米颗粒追踪分析定量血清囊泡,用多重流式细胞术表征EV表面抗原谱。
- 用精确诊断评分将患者按真实缺血事件可能性分层:不太可能(0–1分)、可能- probable(2–3分)、很可能(4–8分)。
主要发现
- EV浓度在很可能或可能- probable TIA患者中较对照升高(P<0.05)。
- 纳米颗粒浓度与精确诊断评分直接相关(R=0.712;P<0.001)。
- EV免疫捕获后,CD8、CD2、CD62P、黑色素瘤相关硫酸软骨素蛋白聚糖、CD42a、CD44、CD326、CD142、CD31和CD14被鉴定为组间判别标志物。
- ROC曲线分析证实每个标志物单独及由其线性组合衍生的复合标志物均有可靠诊断性能(曲线下面积0.851)。
- 结合选定标志物表达水平的随机森林模型区分很可能TIA的准确率在训练队列为96%、外部验证队列为78.9%。
关键数值与推荐
- 精确诊断评分分层:不太可能0–1分、可能- probable 2–3分、很可能4–8分。
- EV浓度在很可能或可能- probable TIA患者中较对照升高(P<0.05)。
- 纳米颗粒浓度与精确诊断评分直接相关(R=0.712;P<0.001)。
- 复合标志物曲线下面积0.851。
- 随机森林模型区分很可能TIA的准确率训练队列96%、外部验证队列78.9%。
临床怎么用
- EV表面抗原谱或可辅助识别症状很可能由脑缺血引起的TIA患者。
- 基于EV表面抗原特征的算法可能帮助临床医生在疑似TIA患者中判断缺血事件可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Extracellular vesicles (EVs) are promising biomarkers for cerebral ischemic diseases, but not systematically tested in patients with transient ischemic attacks (TIAs). We aimed at (1) investigating the profile of EV-surface antigens in patients with symptoms suspicious for TIA; (2) developing and validating a predictive model for TIA diagnosis based on a specific EV-surface antigen profile. METHODS: We analyzed 40 subjects with symptoms suspicious for TIA and 20 healthy controls from a training cohort. An independent cohort of 28 subjects served as external validation. Patients were stratified according to likelihood of having a real ischemic event using the Precise Diagnostic Score, defined as: unlikely (score 0–1), possible-probable (score 2–3), or very likely (score 4–8). Serum vesicles were quantified by nanoparticle tracking analysis and EV-surface antigen profile characterized by multiplex flow cytometry. RESULTS: EV concentration increased in patients with very likely or possible-probable TIA (P<0.05) compared with controls. Nanoparticle concentration was directly correlated with the Precise Diagnostic score (R=0.712; P<0.001). After EV immuno-capturing, CD8, CD2, CD62P, melanoma-associated chondroitin sulfate proteoglycan, CD42a, CD44, CD326, CD142, CD31, and CD14 were identified as discriminants between groups. Receiver operating characteristic curve analysis confirmed a reliable diagnostic performance for each of these markers taken individually and for a compound marker derived from their linear combinations (area under the curve, 0.851). Finally, a random forest model combining the expression levels of selected markers achieved an accuracy of 96% and 78.9% for discriminating patients with a very likely TIA, in the training and external validation cohort, respectively. CONCLUSIONS: The EV-surface antigen profile appears to be different in patients with transient symptoms adjudicated to be very likely caused by brain ischemia compared with patients whose symptoms were less likely to due to brain ischemia. We propose an algorithm based on an EV-surface-antigen specific signature that might aid in the recognition of TIA.
引用
- Burrello J, Bianco G, Burrello A, et al. Extracellular Vesicle Surface Markers as a Diagnostic Tool in Transient Ischemic Attacks. Stroke. 2021. PMID: 34344167. doi:10.1161/STROKEAHA.120.033170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。